S
Steven R. Feldman
Researcher at Wake Forest University
Publications - 1379
Citations - 43140
Steven R. Feldman is an academic researcher from Wake Forest University. The author has contributed to research in topics: Psoriasis & Medicine. The author has an hindex of 83, co-authored 1227 publications receiving 37609 citations. Previous affiliations of Steven R. Feldman include Research Medical Center & Odense University Hospital.
Papers
More filters
Journal ArticleDOI
Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 2012
TL;DR: This study is a thorough nationwide estimate of the incidence of nonmelanoma skin cancer and provides evidence of continued increases in numbers of skin cancer diagnoses and affected patients in the United States.
Journal ArticleDOI
Psoriasis causes as much disability as other major medical diseases.
TL;DR: Different aspects of psoriasis are related to the different dimensions of HRQL supporting the need for multidimensional treatment models, similar to that of other major medical diseases.
Journal ArticleDOI
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer,Mark E. Dudley,Sadik H. Kassim,Robert Somerville,Robert O. Carpenter,Maryalice Stetler-Stevenson,James Chih-Hsin Yang,Giao Q. Phan,Michael S. Hughes,Richard M. Sherry,Mark Raffeld,Steven R. Feldman,Lily Lu,Yong F. Li,Lien T. Ngo,Andre Goy,Tatyana Feldman,David Spaner,Michael L. Wang,Clara C. Chen,Sarah M. Kranick,Avindra Nath,Debbie-Ann N. Nathan,Kathleen E. Morton,Mary Ann Toomey,Steven A. Rosenberg +25 more
TL;DR: The results demonstrate the feasibility and effectiveness of treating chemotherapy-refractory B-cell malignancies with anti-CD19 CAR T cells and provide strong support for further development of this approach.
Journal ArticleDOI
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter,Alice B. Gottlieb,Steven R. Feldman,Abby S. Van Voorhees,Craig L. Leonardi,Kenneth B. Gordon,Mark Lebwohl,John Koo,Craig A. Elmets,Neil J. Korman,Karl R. Beutner,Reva Bhushan +11 more
TL;DR: The classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues; and the safety and efficacy of the biologic treatments used to treat patients with Psoriasis are discussed.
Journal ArticleDOI
Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006
Howard W. Rogers,Martin A. Weinstock,Ashlynne R. Harris,Michael R Hinckley,Steven R. Feldman,Alan B. Fleischer,Brett M. Coldiron +6 more
TL;DR: The number of skin cancers in Medicare beneficiaries increased dramatically over the years 1992 to 2006, due mainly to an increase in the number of affected individuals.